A61K 2236/333
Using mixed solvents
Official title: using mixed solvents, e.g. 70% EtOH
A61K2236/333 (Using mixed solvents) appears on 411 US grants and 895 published applications in this corpus.
Search patents in A61K- Granted patents
- 411
- Published applications
- 895
- Assignees
- 587
- Inventors
- 2,462
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 1 | 6 |
| 2013 | 4 | 10 |
| 2014 | 0 | 9 |
| 2015 | 4 | 14 |
| 2016 | 4 | 23 |
| 2017 | 9 | 42 |
| 2018 | 7 | 37 |
| 2019 | 37 | 49 |
| 2020 | 34 | 89 |
| 2021 | 47 | 123 |
| 2022 | 58 | 119 |
| 2023 | 65 | 113 |
| 2024 | 56 | 120 |
| 2025 | 46 | 70 |
| 2026 | 38 | 65 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Carotenoid preparations, preparation methods, and application thereof6 Oct 2026US 12,751,924 B2Innobio Corporation Limited
- Composition for inhibiting proliferation of tumor comprising Rubus coreanus extract as effective component6 Oct 2026US 12,751,986 B2Korea Institute of Oriental Medicine
- Bertholletia excelsa extract and use thereof29 Sep 2026US 12,746,195 B2Clariant Brasil LTDA.
- Ginseng composition and use thereof as a medicament29 Sep 2026US 12,746,265 B2Botalys SA
- Bioactive phytochemicals in Zizyphus and guarana29 Sep 2026US 12,747,206 B2Phytoquest Limited
- Combination therapy glucocorticoids and ginsenoside8 Oct 2026US 2026/0306525 A1Fytagoras
- Vitality improving agent, composition for improving vitality, and food composition for improving vitality1 Oct 2026US 2026/0294989 A1Arakawa Chemical Industries, Ltd.
- Use of Deep Eutectic Solvent Extract of Chinese Medicinal Herb Composition1 Oct 2026US 2026/0294991 A1Chloex Biotech Co., Ltd.
- Composition for oral use with hmg-coa reductase enzyme inhibiting activity1 Oct 2026US 2026/0294995 A1Difass International S.P.A.
- Composition for preventing, ameliorating or treating eye diseases24 Sep 2026US 2026/0284130 A1Julia Laboratory Inc.
Most cited
By later US patents
- Methods of treating tuberous sclerosis complex with cannabidiol and everolimus43US 11,160,795 B2GW Research Limited · 2021
- Methods of treating tuberous sclerosis complex with cannabidiol and everolimus29US 11,406,623 B2GW Research Limited · 2022
- Lipid comprising docosapentaenoic acid26US 9,718,759 B2Commonwealth Scientific and Industrial Research Organisation · 2017
- Lipid comprising long chain polyunsaturated fatty acids25US 9,725,399 B2Commonwealth Scientific and Industrial Research Organisation · 2017
- Closed-loop multi-stage chilled filter system14US 10,245,525 B1Nextleaf Solutions Ltd. · 2019